Human ZBTB33/ZNF-kaiso/ ZNF348 ORF/cDNA clone-Adenovirus particle (NM_001184742.1)

Pre-made Human ZBTB33/ZNF-kaiso/ ZNF348 Adenovirus for ZBTB33 overexpression in-vitro and in-vivo. The ZBTB33 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified ZBTB33-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.

At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.

Target products collectionGo to ZBTB33/ZNF-kaiso products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)



Product information

Catalog No. Product Name Adenovirus Grade Adenovirus quantity
vGMAD000086 Human ZBTB33 Adenovirus particle Research Grade-In vitro 1E+10PFU (1E+10pfu/ml×1ml)
5E+10PFU (1E+10pfu/ml×5ml)
1E+11PFU (1E+10pfu/ml×10ml)
Research Grade-In vivo 1E+11PFU (1E+11pfu/ml×1ml)
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMAD000086
Gene Name ZBTB33
Accession Number NM_001184742.1
Gene ID 10009
Species Human
Product Type Adenovirus particle (overexpression)
Insert Length 2019 bp
Gene Alias ZNF-kaiso, ZNF348
Fluorescent Reporter
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-MP2391-Ab Anti-KAISO/ ZBTB33/ ZNF-kaiso monoclonal antibody
    Target Antigen GM-Tg-g-MP2391-Ag ZBTB33 VLP (virus-like particle)
    ORF Viral Vector pGMAD000086 Human ZBTB33 Adenovirus plasmid
    ORF Viral Vector pGMLP001312 Human ZBTB33 Lentivirus plasmid
    ORF Viral Vector vGMAD000086 Human ZBTB33 Adenovirus particle
    ORF Viral Vector vGMLP001312 Human ZBTB33 Lentivirus particle


    Target information

    Target ID GM-MP2391
    Target Name ZBTB33
    Gene ID 10009, 56805, 695801, 501506, 101086378, 100685062, 784871, 100062002
    Gene Symbol and Synonyms E130014G12Rik,Kaiso,RGD1566309,ZBTB33,ZNF-kaiso,ZNF348
    Uniprot Accession Q86T24
    Uniprot Entry Name KAISO_HUMAN
    Protein Sub-location Transmembrane Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000177485
    Target Classification Not Available

    This gene encodes a transcriptional regulator with bimodal DNA-binding specificity, which binds to methylated CGCG and also to the non-methylated consensus KAISO-binding site TCCTGCNA. The protein contains an N-terminal POZ/BTB domain and 3 C-terminal zinc finger motifs. It recruits the N-CoR repressor complex to promote histone deacetylation and the formation of repressive chromatin structures in target gene promoters. It may contribute to the repression of target genes of the Wnt signaling pathway, and may also activate transcription of a subset of target genes by the recruitment of catenin delta-2 (CTNND2). Its interaction with catenin delta-1 (CTNND1) inhibits binding to both methylated and non-methylated DNA. It also interacts directly with the nuclear import receptor Importin-α2 (also known as karyopherin alpha2 or RAG cohort 1), which may mediate nuclear import of this protein. Alternatively spliced transcript variants encoding the same protein have been identified.[provided by RefSeq, May 2010]



    About GMVC

    GDU



    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.